Skip to main content
. 2022 Jun 1;13:864545. doi: 10.3389/fimmu.2022.864545

Table 3.

Multivariable Cox regression predicting post-transplant survival.

O.R. 95% C.I. P value
Induction (Basiliximab) 1.41 1.06 - 1.87 0.02
Diagnosis-Obstructive ref ref ref
Diagnosis-Pulmonary hypertension 0.75 0.42 - 1.35 0.34
Diagnosis-Suppurative 0.68 0.45 - 1.02 0.06
Diagnosis-Restrictive 1.02 0.78 - 1.34 0.89
Lung allocation score 1 0.99 - 1.00 0.24
Recipient CMV positive 1.49 1.11 - 2.00 0.01
CMV Mismatch 1.13 0.79 - 1.62 0.51
Oncology history 1.2 0.85 - 1.68 0.3
Any grade 3 primary graft dysfunction Within 72 Hours 1.21 0.93 - 1.58 0.16
Treatment acute cellular rejection in First Year 0.84 0.67 - 1.06 0.13
Postoperative hepatic dysfunction 2.2 1.62 - 2.99 < 0.001
Acute kidney injury requiring renal replacement therapy 2.27 1.73 - 2.98 < 0.001

Odds ratio for death are reported (OR>1 implies an increased risk of death).